Stuart Peltz
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Stuart Peltz
Stuart Peltz was last confirmed as CEO and Board Member at Ptc Therapeutics, Inc. (PTCT) in a filing dated April 28, 2022. The proxy statement of Ptc Therapeutics, Inc. reports total compensation of $7,759,441 for Stuart Peltz in fiscal 2019, including a base salary of $702,000. Disclosed compensation is on record for 3 fiscal years. Stuart Peltz has spoken on 12 earnings calls across 1 company, most recently for Ptc Therapeutics, Inc. on January 9, 2023.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2022-04-28
Last confirmed by a filing; no departure on record
-
Start not stated–2022-04-28
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2019 | Ptc Therapeutics, Inc. (PTCT) | Chief Executive Officer | $702,000 | $7,759,441 |
| 2018 | Ptc Therapeutics, Inc. (PTCT) | Chief Executive Officer | $658,819 | $4,016,735 |
| 2017 | Ptc Therapeutics, Inc. (PTCT) | Chief Executive Officer | $636,540 | $2,172,683 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.